Relay Therapeutics RLAY
NASDAQ RLAY
$18.83 +0.34 (+1.81%)
As of: Oct 2, 2026 · 1:26 PM EDT

Relay Therapeutics (RLAY) Long-Term Investments (2019 - 2026)

Updated

Relay Therapeutics' Long-Term Investments came in at $789.75 million for Q2 2026, up 45.5% from $542.83 million a year earlier and up 80.5% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Long-Term Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Relay Therapeutics' Long-Term Investments was $470.5 million, down 28.4% from FY2024.

  • Long-Term Investments carries a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
  • Going back by year, Long-Term Investments was $657.04 million in FY2024 (+8.4%), $606.35 million in FY2023 (-28.4%), $847.12 million in FY2022 (+25.0%) and $677.95 million in FY2021 (+194.2%).
  • The Q2 2026 figure represents the highest quarterly Long-Term Investments since Q4 2022.
  • Year-over-year, Long-Term Investments increased in four of the last eight quarters, with an average decline of 3.1%.
  • The fastest year-over-year change in Long-Term Investments over five years came in Q4 2021 (growth of 194.2%), and the weakest in Q1 2026 (a decline of 29.1%).
  • Business Quant data shows RLAY's Long-Term Investments at $437.48 million (Q1 2026), $470.5 million (Q4 2025) and $504.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Relay Therapeutics 3.94 Bn 3.94 Bn - 789.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 789.75 Mn
Mar 31, 2026 437.48 Mn
Dec 31, 2025 470.50 Mn
Sep 30, 2025 504.87 Mn
Jun 30, 2025 542.83 Mn
Mar 31, 2025 616.81 Mn
Dec 31, 2024 657.04 Mn
Sep 30, 2024 687.25 Mn
Jun 30, 2024 554.29 Mn
Mar 31, 2024 596.74 Mn
Dec 31, 2023 606.35 Mn
Sep 30, 2023 659.29 Mn
Jun 30, 2023 725.67 Mn
Mar 31, 2023 776.53 Mn
Dec 31, 2022 847.12 Mn
Sep 30, 2022 699.15 Mn
Jun 30, 2022 730.25 Mn
Mar 31, 2022 778.73 Mn
Dec 31, 2021 677.95 Mn
Sep 30, 2021 387.95 Mn
API Access

Relay Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=RLAY&period=max&api_key=YOUR_API_KEY